FDA Drug Application (090526) for OXYBUTYNIN by BARR LABS DIV TEVA

Back to FDA Applications sponsored by BARR LABS DIV TEVA

Application Number090526
Product Number001
FormFILM, EXTENDED RELEASE;TRANSDERMAL
Dosage3.9MG/24HR
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameOXYBUTYNIN
Active IngredientOXYBUTYNIN

Active IngredientCount
List of drugs with Active Ingredient OXYBUTYNIN4


Back to FDA Applications sponsored by BARR LABS DIV TEVA